Assignee
JENIVISION INC
US·5 granted patents·7 pending applications·9 citations·filing 2015–2023
Top patents by PatentIndex Score
12 records- 0188US11857537B2Use of prostacyclin antagonists for treating ocular surface nociceptionJENIVISION INC·Filed 2021·Granted Jan 2, 2024·1 cites·16 claims
- 0286US11478437B2Formulations for hair growthJENIVISION INC·Filed 2017·Granted Oct 25, 2022·2 cites·18 claims
- 0386US9820954B2Quantitative peri-orbital application of ophthalmology drugsJENIVISION INC·Filed 2015·Granted Nov 21, 2017·3 cites·29 claims
- 0483US9827225B2Use of prostacyclin antagonists for treating ocular surface nociceptionJENIVISION INC·Filed 2016·Granted Nov 28, 2017·3 cites·8 claims
- 0580US12478593B2Formulations for hair growthJENIVISION INC·Filed 2023·Granted Nov 25, 2025·0 cites·17 claims
- 0673US2020345697A1Use of prostacyclin antagonists for treating ocular surface nociceptionJENIVISION INC·Filed 2019·Application pending·0 cites
- 0765US2023372274A1Compositions and methods for periorbital administration of ep2 receptor agonistsJENIVISION INC·Filed 2023·Application pending·0 cites
- 0862US2024350447A1Delivery methods for treating brain and central nervous system diseasesJENIVISION INC·Filed 2022·Application pending·0 cites
- 0961US2023107467A1Formulations for hair growthJENIVISION INC·Filed 2022·Application pending·0 cites
- 1059US2024041832A1Methods and compositions for treating eye diseasesJENIVISION INC·Filed 2022·Application pending·0 cites
- 1158US2018008578A1Use of prostacyclin antagonists for treating ocular surface nociceptionJENIVISION INC·Filed 2017·Application pending·0 cites
- 1251US2022218630A1Methods and formulations for treating vision disordersJENIVISION INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →